As of 2025-09-16, the Relative Valuation of Black Diamond Therapeutics Inc (BDTX) is 3.44 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.19 USD, the upside of Black Diamond Therapeutics Inc based on Relative Valuation is 7.7%.
The range of the Relative Valuation is 3.38 - 4.25 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 15.3x | 13.6x |
| Forward P/E multiples | 13.3x - 16.8x | 13.5x |
| Fair Price | 3.38 - 4.25 | 3.44 |
| Upside | 5.9% - 33.2% | 7.7% |
| Date | P/E |
| 2025-09-12 | 12.82 |
| 2025-09-11 | 13.29 |
| 2025-09-10 | 12.66 |
| 2025-09-09 | 12.82 |
| 2025-09-08 | 12.03 |
| 2025-09-05 | 11.59 |
| 2025-09-04 | 11.32 |
| 2025-09-03 | 11.36 |
| 2025-09-02 | 11.04 |
| 2025-08-29 | 10.84 |
| 2025-08-28 | 11.24 |
| 2025-08-27 | 11.32 |
| 2025-08-26 | 11.44 |
| 2025-08-25 | 11.32 |
| 2025-08-22 | 11.51 |
| 2025-08-21 | 10.69 |
| 2025-08-20 | 10.25 |
| 2025-08-19 | 10.45 |
| 2025-08-18 | 10.84 |
| 2025-08-15 | 10.88 |
| 2025-08-14 | 11.00 |
| 2025-08-13 | 10.92 |
| 2025-08-12 | 10.02 |
| 2025-08-11 | 9.11 |
| 2025-08-08 | 9.46 |
| 2025-08-07 | 8.99 |
| 2025-08-06 | 10.61 |
| 2025-08-05 | 10.77 |
| 2025-08-04 | 11.16 |
| 2025-08-01 | 10.21 |
| 2025-07-31 | 10.49 |
| 2025-07-30 | 11.12 |
| 2025-07-29 | 10.96 |
| 2025-07-28 | 11.55 |
| 2025-07-25 | 11.71 |
| 2025-07-24 | 12.30 |
| 2025-07-23 | 12.58 |
| 2025-07-22 | 12.58 |
| 2025-07-21 | 12.42 |
| 2025-07-18 | 12.34 |
| 2025-07-17 | 12.66 |
| 2025-07-16 | 11.99 |
| 2025-07-15 | 11.63 |
| 2025-07-14 | 11.59 |
| 2025-07-11 | 11.32 |
| 2025-07-10 | 10.81 |
| 2025-07-09 | 10.41 |
| 2025-07-08 | 9.86 |
| 2025-07-07 | 9.86 |
| 2025-07-03 | 10.17 |